While human studies have not found a correlation between blood IFNγ and protection against TB, our recent mechanistic studies suggest that rapid pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells producing IFNγ appears to be one of the mechanisms underlying BCG vaccine-induced immunity against primary TB [9]. Here, CD8A is linked to tuberculosis.